Author:
Hayashi Shin-ichi,Sakamoto Takako,Inoue Akio,Yoshida Nobuyuki,Omoto Yoko,Yamaguchi Yuri
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference43 articles.
1. Early Breast Cancer Trialists’ Collaborative Group, Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet 351 (1998) 1451–1467.
2. The Comprehensive Cancer Centres’ ALERT Group, L. Bergman, M.L.R. Beelen, M.P.W. Gallee, H. Hollema, J. Benraadt, F.E. van Leeuwen, Risk and prognosis of endometrial cancer after tamoxifen for breast cancer, Lancet 356 (2000) 881–887.
3. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers;Fornander;Lancet,1989
4. other National Surgical Adjuvant Breast and Bowel Project investigators, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J. Natl. Cancer Inst.,1998
5. Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line);Anzai;Cancer Res.,1989
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献